K-V Pharmaceutical Announces Updated Makena® Performance Metrics bi13281172 ST. LOUIS, Nov. 8, 2011 /PRNewswire/ -- K-V Company (NYSE: KV.A/ KV.B) (the "Company" or "K-V"), today reported updated performance metrics for Makena®, the only U.S. Food & Drug Administration ("FDA") approved product indicated to reduce the risk of preterm birth..

K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17- bi13281172 K-V Company appreciates that the American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine have issued an information update that ensures healthcare providers, patients, and the payer community have the facts regarding FDA-approved Makena?

K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hyd bi13281172 K-V Company appreciates the decision of the American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine to issue an information update and ensure that healthcare providers, patients, and the payer community have the facts regarding FDA-approved Makena?

Food, Drug, Medical Device Recalls Continue to Climb According to ExpertRECAL bi13281172 INDIANAPOLIS, Nov. 3, 2011 /PRNewswire/ -- Food recalls the third quarter affected nearly six times as many units as the previous three-month period, according to the quarterly ExpertRECALL? Index, released today. The ExpertRECALL Index also found that ..

Glaxo, Jazz Pharmaceuticals Cited by FDA bi13281172 GlaxoSmithKline and Jazz s were both cited by the U.S. Food and Drug Administration (FDA) over a number of violations. The Jazz plant California and the GlaxoSmithKline facility the United Kingdom are involved. The FDA sent a warning letter to Jazz s Inc. over concerns about violations at California plant, said Bloomberg []..

Photographic Memory: Wearable Cam Could Help Patients Stave Off Effects of Im bi13281172 Hopes for new Alzheimer's drugs that would slow or stop the disease's inexorable decline have repeatedly foundered recent years. Large companies, have pushed ahead drugs that stop the buildup of toxic proteins that damage and kill brain cells, have reported a recurring string of bad news. Just one example: Eli Lilly had to suspend last year the trial of a ..

K-V Pharmaceutical Announces Updated Makena® Performance Metrics bi13281172 ST. LOUIS, Nov. 8, 2011 /PRNewswire/ -- K-V Company (NYSE: KV.A/ KV.B) (the "Company" or "K-V"), today reported updated performance metrics for Makena®, the only U.S. Food & Drug Administration ("FDA") approved product indicated to reduce the risk of preterm birth..

K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17- bi13281172 K-V Company appreciates that the American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine have issued an information update that ensures healthcare providers, patients, and the payer community have the facts regarding FDA-approved Makena?

K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hyd bi13281172 K-V Company appreciates the decision of the American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine to issue an information update and ensure that healthcare providers, patients, and the payer community have the facts regarding FDA-approved Makena?

Food, Drug, Medical Device Recalls Continue to Climb According to ExpertRECAL bi13281172 INDIANAPOLIS, Nov. 3, 2011 /PRNewswire/ -- Food recalls the third quarter affected nearly six times as many units as the previous three-month period, according to the quarterly ExpertRECALL? Index, released today. The ExpertRECALL Index also found that ..

Glaxo, Jazz Pharmaceuticals Cited by FDA bi13281172 GlaxoSmithKline and Jazz s were both cited by the U.S. Food and Drug Administration (FDA) over a number of violations. The Jazz plant California and the GlaxoSmithKline facility the United Kingdom are involved. The FDA sent a warning letter to Jazz s Inc. over concerns about violations at California plant, said Bloomberg []..

Photographic Memory: Wearable Cam Could Help Patients Stave Off Effects of Im bi13281172 Hopes for new Alzheimer's drugs that would slow or stop the disease's inexorable decline have repeatedly foundered recent years. Large companies, have pushed ahead drugs that stop the buildup of toxic proteins that damage and kill brain cells, have reported a recurring string of bad news. Just one example: Eli Lilly had to suspend last year the trial of a ..

KV, Hermelin offer competing versions of blame for drugmaker's meltdown bi13281172 The trouble at KV Co. ? ultimately leading to criminal convictions and mass layoffs ? turned on a fateful 2008 decision not to recall oversize drug tablets and alert the authorities

Xbox Backup Software - Home